Pharmacokinetic profile of Risperidone ISM (R) after switching from oral EU risperidone at steady-state: an open-label, one-sequence bioavailability trial (BORIS-2)

D. Walling, L. Anta, H. Hassman,R. Litman, L. Ochoa, J. Llaudo,J. Martinez,I Gutierro

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要